English

NATTO: 2017 Half Year Earnings Release

Report this content

Please find attached the Nattopharma Group 2017 Half Year Earnings Release.

Financial highlights for the First Half of 2017 are;  

  • Revenue rose by 18,6% to NOK 30,6 million
  • Gross Margin for the period was 45,8 %,
  • Positive adjusted EBITDA of NOK 1,5 million for the supplement business


A presentation will be held via webcast by CEO Daniel H. Rosenbaum and CFO Kjetil Ramsøy at 10 am CET, Wednesday 16th August 2017, followed by a Q&A session directly thereafter.

Please follow the below link to join the webcast;

http://webtv.hegnar.no/presentation.php?webcastId=63184487  



For more information, please contact:

Kjetil Ramsøy

CFO, NattoPharma

E-mail: kjetil.ramsoy@nattopharma.com

This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

Tags:

osteoporosis cardiovascular health Vitamin K2 NattoPharma MenaQ7 Natural Vitamin K2

Documents & Links